Tackling PD1i resistance in Hodgkin lymphoma
Blood
.
2023 Oct 19;142(16):1333-1334.
doi: 10.1182/blood.2023021283.
Author
Graham P Collins
1
Affiliation
1
Churchill Hospital.
PMID:
37856096
DOI:
10.1182/blood.2023021283
No abstract available
Publication types
Editorial
Comment
MeSH terms
Hodgkin Disease* / drug therapy
Hodgkin Disease* / pathology
Humans
Lymphoma, Non-Hodgkin*
Programmed Cell Death 1 Receptor
Vorinostat
Substances
pembrolizumab
Programmed Cell Death 1 Receptor
Vorinostat